��������

Mr. Stang is the founder of Lumitron Technology and its executive Chairman. Mr. Stang is also the founder of a number of other successful companies internationally, in the healthcare and technology sectors. These companies span, biotechnology, medical devices and a number of innovations in the “clean-tech” sector. He is currently the Chairman of Nanosonics Limited (ASX:NAN) and Aeris Environmental Limited (ASX:AEI), which are both listed on the Australian Securities Exchange. In addition, he is a founder and director of Henry Schein Halas, a joint venture with the NASDAQ-listed Henry Schein, Inc.

Mr. Stang has also established a number of prominent private companies covering research and development, large scale healthcare distribution and several other highly innovative businesses. These companies have gained market leadership in their respective fields and many have won significant innovation and export awards together with strategic partnerships and licensing agreements with some of the worlds leading companies including GE, 3M, Johnson and Johnson, Getinge and Ecolabs.

Mr. Stang’s business activities and experience span the commercialization of intellectual property across global markets. He has a track record of launching and commercializing a broad range of medical and dental devices. Mr. Stang is also a Principal of Gryphon Capital Pty Limited, an independent investment house that facilitates the financing and development of emerging health-care related entities.